Amniotic tissue lab
Cairo, 29, Egypt
NCT Number: NCT03440528
To evaluate the using of a commercial product of dried human amniotic membrane sterilized by gamma irradiation for the treatment of skin ulcer.
Looking for future studies?
Notify MeAll sexes
Observational
Cairo, 29, Egypt
Dried human amniotic membrane patches were obtained from National center for radiation research and technology, Egypt, under commercial name REGE pro.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 week
REGE pro decreased size of ulcer after second treatment
Time frame: 1 week
Patients response revealed reduction of pain at the time of application. One week post application, a questionnaire were collected from patients; about 95% of them ensured that pain was controlled.
Time frame: 4 to 10 weeks
REGE pro healed ulcer after 4 to 10 weeks. The improvement of ulcer was observed by photographs taken before and each week post application.
Time frame: 10 weeks
It was observed that the using of REGE pro prevent any scar formation in all applied patients.
Egyptian Atomic Energy Authority
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02535481
Pathologic Processes, Pathological Conditions, Signs and Symptoms
London, United Kingdom
View Trial DetailsNCT01770509
Cardiovascular Diseases, Leg Ulcer
Ramat Gan, Israel
View Trial DetailsNCT06674980
Cardiovascular Diseases, Diabetes Complications
Metairie, Louisiana, United States
View Trial DetailsNCT06742983
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Ismailia, Egypt
View Trial Details